Phase II study establishes feasibility, safety of pioneering restenosis treatment Aug. 28, 1998 No Comments
News from the ACS: Lilly investigates antioxidants for treating neuronal injury Aug. 28, 1998 No Comments
Preclinical and clinical data reported for orbofiban, a potent antiplatelet agent Aug. 28, 1998 No Comments
AR-C69931MX; a novel P2T antagonist with platelet aggregation-inhibitory activity Aug. 28, 1998 No Comments
RSS